Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
Latest newsMore news →
Santen Pharmaceutical announced that China's drug regulator accepted its marketing approval application for the myopia-progression-suppressing eye drop Ryjusea.6d agoSanten Pharmaceutical announced it will join the inaugural Global Summit for Eye Health as a High-Impact Partner, organized by IAPB in collaboration with WHO, to help shape the Global Eye Health Compact and unveil its global eye health commitment.46d ago